Skip to content

Short squeeze alert: Two stocks that could take off in September

Short squeeze alert: Two stocks that could take off in September
Kliment Dukovski

Trading a short squeeze is a popular strategy because the stock price can go beyond real valuation. The way it works is traders borrow a certain stock, they sell it with the hope of buying it back cheaper and returning the stock to the lender. However, when millions of shares are bought back, it’s likely to drive the stock price higher, which is how you can profit.

Because the interest for shorted stocks remains, Finbold analyzed the most shorted stocks this year on August 31 and selected the two with the highest potential to soar in the future as the market prepares to head into September.

Novavax (NASDAQ: NVAX)

Novavax is a biotech company that develops and commercializes vaccines to prevent serious diseases. The company has developed a COVID-19 vaccine, and now with the re-emergence of new strains, it could provide a good marketplace for its products.

The company is one of the most shorted stocks at 45.79% of the float, as of August data. In other words, almost 40 million shares are shorted out of 86 million shares floating. If a short squeeze happens, it could be massive.

Morningstar’s equity report has put a fair value of $17.57 per share. That’s 110% above the current market price of $8.36.

Morningstar quantitative equity report for NVAX. Source: Interactive Brokers Fundamentals Explorer

Fisker Inc (NYSE: FSR)

Fisker is a California-based electric vehicle manufacturer. For the moment, Fisker sells only one vehicle, the Fisker Ocean, which is an all-electric SUV. More vehicles are being designed and developed, though, like the Ronin sports car and the Alaska lightweight pick-up truck.

The company is one of the top 10 most shorted stocks with 42.57% of the float, as of August data. That’s an increase from 25% a month ago. 

Morningstar’s equity report has provided a $9.51 fair value for the FSR stock. With the stock currently trading at $5.79, that’s a 64% difference.

Morningstar quantitative equity report for FSR. Source: Interactive Brokers Fundamentals Explorer

Novavax is down 14% year to date, while Fisker is down 15% during the same period. The S&P 500’s 18% return has outperformed both so far.

Buy stocks now with Interactive Brokers – the most advanced investment platform

Disclaimer: The content on this site should not be considered investment advice. Investing is speculative. When investing, your capital is at risk.

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Services

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.